New Weight Loss Medicine Might Have Cardiorenal Advantages for Sufferers with Kidney Illness
Glycogen-like peptide-1 receptor antagonists (GLP-1 RAs) and sodium glucose contransporter-2 (SGLT2) inhibitors will have cardioprotective results for sufferers with continual kidney illness (CKD), in keeping with Alexander R. Chang, MD, MS, a